{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:11:25Z","timestamp":1778717485091,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"DOI":"10.1186\/s40170-026-00429-2","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:37:37Z","timestamp":1775209057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of mitochondria amount and clearance using flow cytometry: effect of mitophagy inhibitors in leukemia cells"],"prefix":"10.1186","volume":"14","author":[{"given":"Tereza","family":"Ko\u0159\u00e1nov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Grebe\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate\u0159ina","family":"Ku\u017eelov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"429_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell stem cell","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell stem cell. Vol. 12. United States: Elsevier Inc; 2013. p. 329\u201341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013."},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","volume":"36","author":"de Beauchamp L","year":"2022","unstructured":"de Beauchamp L, Himonas E, Helgason GV. Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia. Leukemia [Internet]. 2022;36:1\u201312. https:\/\/doi.org\/10.1038\/s41375-021-01416-w.","journal-title":"Leukemia"},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol [Internet]. 2018;28:R170\u201385. https:\/\/doi.org\/10.1016\/j.cub.2018.01.004.","journal-title":"Curr Biol"},{"key":"429_CR4","doi-asserted-by":"crossref","unstructured":"Tjahjono E, Daneman MR, Meika B, Revtovich A V, Kirienko N V. Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia. Front Oncol [Internet]. 2025;Volume:14\u20132024. https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1532857.","DOI":"10.3389\/fonc.2024.1532857"},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","volume-title":"Cell stem cell","author":"S Pei","year":"2018","unstructured":"Pei S, Minhajuddin M, Adane B, Khan N, Stevens BM, Mack SC, et al. AMPK\/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. In: Cell stem cell [Internet]. 23. United States: Elsevier Inc; 2018. p. 86\u2013100.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.05.021."},{"key":"429_CR6","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1002\/cpcb.99","volume-title":"A sensitive and quantitative mKeima Assay for mitophagy via FACS. Curr protoc cell Biol","author":"C Wang","year":"2020","unstructured":"Wang C. A sensitive and quantitative mKeima assay for mitophagy via FACS. Curr Protoc Cell Biol. United States: The Authors; 2020;86:e99. https:\/\/doi.org\/10.1002\/cpcb.99."},{"key":"429_CR7","first-page":"1233","volume-title":"HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression","author":"P Martin","year":"1982","unstructured":"Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science. UNITED STATES; 1982. p. 1233\u201335."},{"key":"429_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","volume":"14","author":"A Cassidy-Stone","year":"2008","unstructured":"Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, et al. Chemical inhibition of the mitochondrial division dynamin reveals Its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell [Internet]. 2008;14:193\u2013204. https:\/\/doi.org\/10.1016\/j.devcel.2007.11.019.","journal-title":"Dev Cell"},{"key":"429_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2162-3619-1-15","volume":"1","author":"W Zhao","year":"2012","unstructured":"Zhao W, Du Y, Ho WT, Fu X, Zhao ZJ. JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines. Exp Hematol Oncol [Internet]. 2012;1:15. https:\/\/doi.org\/10.1186\/2162-3619-1-15.","journal-title":"Exp Hematol Oncol"},{"key":"429_CR10","doi-asserted-by":"publisher","unstructured":"Li Y, Li Y, Yin J, Wang C, Yang M, Gu J, et al. A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Lett. Ireland: Elsevier B.V; 2021;510:24\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.003.","DOI":"10.1016\/j.canlet.2021.04.003"},{"key":"429_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2018-02-833475","volume-title":"Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy","author":"TD Nguyen","year":"2019","unstructured":"Nguyen TD, Shaid S, Vakhrusheva O, Koschade SE, Klann K, Th\u00f6lken M, et al. Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. United States: by The American Society of Hematology; 2019. Vol. 133. p. 168\u201379. https:\/\/doi.org\/10.1182\/blood-2018-02-833475."},{"key":"429_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/15548627.2018.1558002","volume-title":"Autophagy","author":"R Rodrigo","year":"2019","unstructured":"Rodrigo R, Nilmini M, Medhat I, Christina M, Elena K, Alessia R, et al. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs. In: Autophagy [Internet]. 15. Taylor & Francis; 2019. p. 900\u201307. https:\/\/doi.org\/10.1080\/15548627.2018.1558002."},{"key":"429_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume-title":"Autophagy","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Idil O, Cecilia R, Xingdong Z, Morten L, Kerst-Jan H, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. In: Autophagy [Internet]. 14. Taylor & Francis; 2018. p. 1435\u201355. https:\/\/doi.org\/10.1080\/15548627.2018.1474314."},{"key":"429_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-020-2238-1","volume":"11","author":"F Zhang","year":"2020","unstructured":"Zhang F, Peng W, Zhang J, Dong W, Wu J, Wang T, et al. P53 and Parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head. Cell Death Dis [Internet]. 2020;11:42. https:\/\/doi.org\/10.1038\/s41419-020-2238-1.","journal-title":"Cell Death Dis"},{"key":"429_CR15","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/ncomms3308","volume":"4","author":"A Hoshino","year":"2013","unstructured":"Hoshino A, Mita Y, Okawa Y, Ariyoshi M, Iwai-Kanai E, Ueyama T, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun [Internet]. 2013;4:2308. https:\/\/doi.org\/10.1038\/ncomms3308.","journal-title":"Nat Commun"},{"key":"429_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-017-0016-0","author":"T Goiran","year":"2018","unstructured":"Goiran T, Duplan E, Rouland L, Manaa W, Lauritzen I, Dunys J, et al. Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation. Cell Death Differ [Internet]. 2018. https:\/\/doi.org\/10.1038\/s41418-017-0016-0.","journal-title":"Cell Death Differ"},{"key":"429_CR17","doi-asserted-by":"crossref","unstructured":"Molica M, Mazzone C, Niscola P, de Fabritiis P. TP53 mutations in acute myeloid leukemia: still a daunting challenge? Front Oncol [Internet]. 2021;Volume:10\u20132020. https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2020.610820.","DOI":"10.3389\/fonc.2020.610820"},{"key":"429_CR18","doi-asserted-by":"publisher","unstructured":"Yang F, Brady SW, Tang C, Sun H, Du L, Barz MJ, et al. Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse. Nat Cancer [Internet]. 2021;2:819\u201334. https:\/\/doi.org\/10.1038\/s43018-021-00230-8.","DOI":"10.1038\/s43018-021-00230-8"}],"container-title":["Cancer & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-026-00429-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-026-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-026-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:34:56Z","timestamp":1778715296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40170-026-00429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1186\/s40170-026-00429-2","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}